author-photo

Andrew Flood

OSI Pharmaceuticals

1

Papers

0

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Antitumor activity of OSI-930, a novel multi-targeted tyrosine kinase inhibitor, in combination with standard chemotherapeutics in preclinical cancer models

2005 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)